Pulmonary arterial mechanoreceptors mediate sustained sympathoexcitation during high altitude hypoxia in humans

Sympathetic nervous system activation is a hallmark of high-altitude hypoxia, yet the afferent mechanisms remain incompletely defined. We examined the relative contributions of pulmonary arterial mechanoreceptors and carotid chemoreceptors - two excitatory pathways co-activated by hypoxia - to sustained sympathoexcitation at altitude. Nine healthy lowlanders (27 ± 7 years, three female) were studied after 6-9 days at 3800 m under four conditions: (1) control, (2) inhaled nitric oxide (iNO, 40 ppm) to reduce pulmonary arterial pressure, (3) low-dose dopamine infusion (2 µg kg<sup>-</sup> <sup>1</sup> min<sup>-</sup> <sup>1</sup>) to suppress the carotid chemoreflex, and (4) combined iNO and dopamine. End-tidal oxygen and carbon dioxide were kept constant throughout. We assessed muscle sympathetic nerve activity (MSNA), systemic haemodynamics, ventilation and pulmonary arterial systolic pressure. iNO reduced pulmonary arterial pressure and significantly decreased MSNA (condition 1: 25 ± 8 bursts min<sup>-1</sup> vs. condition 2: 21 ± 7 bursts min<sup>-1</sup>; P = 0.0415), whereas dopamine infusion reduced ventilation (P < 0.001) without a consistent effect on MSNA (condition 1: 25 ± 8 bursts min<sup>-1</sup> vs. condition 3: 28 ± 13 bursts min<sup>-1</sup>; P = 0.112). Combined intervention produced a small reduction in sympathetic nerve activity (condition 3: 28 ± 13 bursts min<sup>-1</sup> vs. condition 4: 26 ± 13 bursts min<sup>-1</sup>; P = 0.0643), likely due to baroreflex engagement. These findings confirm that unloading pulmonary arterial pressure attenuates MSNA, reinforcing the role of pulmonary mechanoreceptors in high altitude sympathoexcitation. Attempts to isolate a carotid chemoreflex contribution were likely confounded by dopamine's haemodynamic effect, which introduced variability and limited the specificity of this intervention. Thus, interpretation of this component remains exploratory, highlighting the integrative complexity of reflex control of high altitude sympathoexcitation in humans.

Authors

Institutions

Publication Details

Journal
Experimental Physiology
Published
2026-02-15
DOI
https://doi.org/10.1113/ep093675
Primary Topic
Neuroscience of respiration and sleep
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulmonary arterial mechanoreceptors mediate sustained sympathoexcitation during high altitude hypoxia in humans

Lydia L. Simpson, Connor A. Howe, Travis D. Gibbons, Samuel J. Oliver et al.
Experimental Physiology
Neuroscience of respiration and sleep
article

Pulmonary arterial mechanoreceptors mediate sustained sympathoexcitation during high altitude hypoxia in humans

Lydia L. Simpson, Connor A. Howe, Travis D. Gibbons, Samuel J. Oliver, Emily R. Vanden Berg, Jonathan P. Moore, Elliott J. Jenkins, Craig D. Steinback, Michiel Ewalts, Lauren Maier, A J Williams, Jack S. Talbot, Mike Stembridge
article en

Abstract

Sympathetic nervous system activation is a hallmark of high-altitude hypoxia, yet the afferent mechanisms remain incompletely defined. We examined the relative contributions of pulmonary arterial mechanoreceptors and carotid chemoreceptors - two excitatory pathways co-activated by hypoxia - to sustained sympathoexcitation at altitude. Nine healthy lowlanders (27 ± 7 years, three female) were studied after 6-9 days at 3800 m under four conditions: (1) control, (2) inhaled nitric oxide (iNO, 40 ppm) to reduce pulmonary arterial pressure, (3) low-dose dopamine infusion (2 µg kg<sup>-</sup> <sup>1</sup> min<sup>-</sup> <sup>1</sup>) to suppress the carotid chemoreflex, and (4) combined iNO and dopamine. End-tidal oxygen and carbon dioxide were kept constant throughout. We assessed muscle sympathetic nerve activity (MSNA), systemic haemodynamics, ventilation and pulmonary arterial systolic pressure. iNO reduced pulmonary arterial pressure and significantly decreased MSNA (condition 1: 25 ± 8 bursts min<sup>-1</sup> vs. condition 2: 21 ± 7 bursts min<sup>-1</sup>; P = 0.0415), whereas dopamine infusion reduced ventilation (P < 0.001) without a consistent effect on MSNA (condition 1: 25 ± 8 bursts min<sup>-1</sup> vs. condition 3: 28 ± 13 bursts min<sup>-1</sup>; P = 0.112). Combined intervention produced a small reduction in sympathetic nerve activity (condition 3: 28 ± 13 bursts min<sup>-1</sup> vs. condition 4: 26 ± 13 bursts min<sup>-1</sup>; P = 0.0643), likely due to baroreflex engagement. These findings confirm that unloading pulmonary arterial pressure attenuates MSNA, reinforcing the role of pulmonary mechanoreceptors in high altitude sympathoexcitation. Attempts to isolate a carotid chemoreflex contribution were likely confounded by dopamine's haemodynamic effect, which introduced variability and limited the specificity of this intervention. Thus, interpretation of this component remains exploratory, highlighting the integrative complexity of reflex control of high altitude sympathoexcitation in humans.

Experimental Physiology
University of British Columbia (CA), Baker Heart and Diabetes Institute (AU), Bangor University (GB), Universität Innsbruck (AT), University of Bristol (GB), Department of Physiological Sciences (RU), Department of Sport and Recreation (AU), Melbourne Health (AU), University of British Columbia, Okanagan Campus (CA), Okanagan University College (CA), Cardiff Metropolitan University (GB)
Life below water
Openalex Percentile: Top 51%
Neuroscience of respiration and sleep
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.